People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monteris Medical US, Inc. | — | Healthtech | Series B | $82.5M | $168.2M | 2014 |
| Clarify Medical, Inc. | — | Healthtech | Series C | $67.6M | $776.1M | 2021 |
| Titan Medical Inc | — | Healthtech | Seed | $10.0M | $63.0M | 2017 |
| Monteris Medical Inc | — | Biotechnology | Seed | $9.0M | $163.1M | 2013 |
John Schellhorn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Schellhorn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Morand | 2 | 5 |
| Gregory Barrett | 2 | 4 |
| James Richardson | 2 | 4 |
| Gary Bantle | 2 | 2 |
| Kevin McGarry | 2 | 2 |
| Daniel Cole | 2 | 2 |
| Robert K Davidson | 2 | 2 |
| David F Hale | 1 | 16 |
| Kirk Nielsen | 1 | 13 |
| PAUL LAVIOLETTE | 1 | 12 |
| Robert Garber | 1 | 8 |
| Bruce Robertson | 1 | 7 |
| STEPHEN RANDALL | 1 | 5 |
| David Hale | 1 | 4 |
| James Reinstein | 1 | 3 |
| Joseph Biller | 1 | 3 |
| Matthew Strobeck | 1 | 3 |
| Rex Bright | 1 | 3 |
| David McNally | 1 | 3 |
| Anthony J. Giovinazzo | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.